GleamWall
中文EN

HYFT MindWalk Holdings Corp. IFRS

Pharmaceutical Preparations · Nasdaq · SEC CIK 1715925 · Reporting currency CAD · Fiscal year ends 04/30

Financial factors as of 2026-01-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY28.5%
TTM net income YoY73.2%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin60.3%
Operating margin—
Net margin-66.5%
FCF margin-64.8%
EBITDA margin—

Returns

ROE-61.5%
ROA-35.7%
ROIC (approx.)—
Asset turnover0.54x

Leverage & solvency

Liabilities / assets35.4%
Debt / equity0.00x
Current ratio3.74x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.91x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue4.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD FY2025*2025-04-30FY2024*2024-04-30
Income statement
Revenue24.52M24.52M
Cost of revenue10.97M12.46M
Gross profit13.55M12.05M
R&D expense4.94M4.04M
SG&A expense14.73M15.59M
Interest expense199,000402,000
Pretax income-34.27M-28.70M
Income tax-4.03M-2.59M
Net income-30.23M-26.11M
EPS (basic)-0.91-1.02
EPS (diluted)-0.91-1.02
Balance sheet
Cash & equivalents10.79M3.54M
Inventory2.10M2.14M
Current assets18.75M11.49M
PP&E, netmay include right-of-use assets (IFRS)15.76M16.70M
Goodwill8.23M7.69M
Intangibles1.07M23.56M
Total assets44.44M59.99M
Current liabilities9.01M8.12M
Total liabilities20.82M24.31M
Shareholders' equity23.63M35.68M
Shares outstanding46.15M26.94M
Cash flow statement
Operating cash flow-6.41M-3.18M
Capital expenditure799,0001.40M
Free cash flow-7.21M-4.58M
Investing cash flow-799,000-1.56M
Financing cash flow14.89M1.02M
Depreciation & amortization5.12M5.74M
Stock-based compensation445,0001.53M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.